689 related articles for article (PubMed ID: 28548953)
1. From rapalogs to anti-aging formula.
Blagosklonny MV
Oncotarget; 2017 May; 8(22):35492-35507. PubMed ID: 28548953
[TBL] [Abstract][Full Text] [Related]
2. Koschei the immortal and anti-aging drugs.
Blagosklonny MV
Cell Death Dis; 2014 Dec; 5(12):e1552. PubMed ID: 25476900
[TBL] [Abstract][Full Text] [Related]
3. Rapalogs and mTOR inhibitors as anti-aging therapeutics.
Lamming DW; Ye L; Sabatini DM; Baur JA
J Clin Invest; 2013 Mar; 123(3):980-9. PubMed ID: 23454761
[TBL] [Abstract][Full Text] [Related]
4. Gerosuppression by pan-mTOR inhibitors.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2016 Dec; 8(12):3535-3551. PubMed ID: 28077803
[TBL] [Abstract][Full Text] [Related]
5. Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).
Leontieva OV; Demidenko ZN; Blagosklonny MV
Oncotarget; 2015 Sep; 6(27):23238-48. PubMed ID: 26177051
[TBL] [Abstract][Full Text] [Related]
6. Rapalogs in cancer prevention: anti-aging or anticancer?
Blagosklonny MV
Cancer Biol Ther; 2012 Dec; 13(14):1349-54. PubMed ID: 23151465
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin extends life- and health span because it slows aging.
Blagosklonny MV
Aging (Albany NY); 2013 Aug; 5(8):592-8. PubMed ID: 23934728
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin, proliferation and geroconversion to senescence.
Blagosklonny MV
Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374
[TBL] [Abstract][Full Text] [Related]
9. New tricks from old dogs join the fight against ageing.
Savage N
Nature; 2017 Dec; 552(7684):S57-S59. PubMed ID: 29239380
[No Abstract] [Full Text] [Related]
10. Dual mTORC1/C2 inhibitors: gerosuppressors with potential anti-aging effect.
Sousa-Victor P; García-Prat L; Muñoz-Cánoves P
Oncotarget; 2015 Sep; 6(27):23052-4. PubMed ID: 26375366
[TBL] [Abstract][Full Text] [Related]
11. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.
Blagosklonny MV
Cell Cycle; 2006 Sep; 5(18):2087-102. PubMed ID: 17012837
[TBL] [Abstract][Full Text] [Related]
12. Cell senescence, rapamycin and hyperfunction theory of aging.
Blagosklonny MV
Cell Cycle; 2022 Jul; 21(14):1456-1467. PubMed ID: 35358003
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin and the inhibition of the secretory phenotype.
Wang R; Sunchu B; Perez VI
Exp Gerontol; 2017 Aug; 94():89-92. PubMed ID: 28167236
[TBL] [Abstract][Full Text] [Related]
14. Targeting mTOR signaling by polyphenols: A new therapeutic target for ageing.
Pazoki-Toroudi H; Amani H; Ajami M; Nabavi SF; Braidy N; Kasi PD; Nabavi SM
Ageing Res Rev; 2016 Nov; 31():55-66. PubMed ID: 27453478
[TBL] [Abstract][Full Text] [Related]
15. The role of mTOR inhibitors and HMG-CoA reductase inhibitors on young and old endothelial cell functions, critical for re-endothelialisation after percutaneous coronary intervention: an in vitro study.
Korybalska K; Kawka E; Breborowicz A; Witowski J
J Physiol Pharmacol; 2017 Jun; 68(3):397-405. PubMed ID: 28820396
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island.
Arriola Apelo SI; Lamming DW
J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):841-9. PubMed ID: 27208895
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin for longevity: opinion article.
Blagosklonny MV
Aging (Albany NY); 2019 Oct; 11(19):8048-8067. PubMed ID: 31586989
[TBL] [Abstract][Full Text] [Related]
18. TOR-inhibitors as gero-suppressors.
Nikiforov M
Aging (Albany NY); 2015 Dec; 7(12):1030-1. PubMed ID: 26796970
[No Abstract] [Full Text] [Related]
19. Drugs that target aging: how do we discover them?
Myers A; Lithgow GJ
Expert Opin Drug Discov; 2019 Jun; 14(6):541-548. PubMed ID: 30973028
[TBL] [Abstract][Full Text] [Related]
20. Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells.
Antonioli E; Torres N; Ferretti M; Piccinato CA; Sertie AL
PLoS One; 2019; 14(1):e0204784. PubMed ID: 30703123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
